ArticleImmunologic research2015
Three conserved MyD88-recruiting TLR residues exert different effects on the human TLR4 signaling pathway.
Article in Immunologic research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 7 citations in OpenAlex.
- The NF-κB Pathway: a Focus on Inflammatory Responses in Spinal Cord Injury.Molecular neurobiology · 2023Review
- TRPC channels blockade abolishes endotoxemic cardiac dysfunction by hampering intracellular inflammation and CaNature communications · 2022Article
- Phosphorylated Heat Shock Protein 27 Inhibits Lipopolysaccharide-Induced Inflammation in Thp1 Cells by Promoting TLR4 Endocytosis, Ubiquitination, and Degradation.Inflammation · 2019Article
- The expression of fibronectin is significantly suppressed in macrophages to exert a protective effect against Staphylococcus aureus infection.BMC microbiology · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stimulation of Toll-like receptor (TLR) 4 leads to the activation of both MyD88-dependent and MyD88-independent pathways through the recruitment of adaptors TIRAP/MyD88 and TRIF/TRAM, respectively. However, the molecular basis of the TLR4 Toll/interleukin-1 receptor (TIR) domain in recruiting these downstream adaptors is still not entirely clear. Here, we identify three amino acid residues (714P in the BB loop, 696L in the αA helix and 721N in the αB sheet) conserved in all MyD88-recruited TLRs, but not the TLR3 TIR domain, as being critical for TLR4 responsiveness to LPS. These results were based on the substitution of each residue with a residue of the opposite type (hydrophilic/hydrophobic). However, the responsiveness of the TLR4 mutants to LPS was only partially decreased when each residue was replaced with a residue having the same hydrophilicity/hydrophobicity. This result is likely associated with an alteration in the BB-loop conformation of each TLR4 mutant and its ability to recruit the downstream adaptor TRAM. Thus, we identified three amino acids essential for TLR4 signaling, and their replacement with a residue of the same or opposite hydrophilicity/hydrophobicity greatly affected TLR4 signaling. This study furthers our understanding of the molecular mechanism by which the TLR4 TIR domain modulates TLR4 signaling and also provides new insight for the design of antisepsis therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.